What is it about?
sugar conjugated silicon nanoparticles for biomedical applications
Featured Image
Why is it important?
low toxicity suitable for targeted and monitored drug delivery
Perspectives
sugar capped luminescent silicon nanoparticles acting as a nanocarrier for future drug delivery
Dr Yimin Chao
University of East Anglia
Read the Original
This page is a summary of: Synthesis of Carbohydrate Capped Silicon Nanoparticles and their Reduced Cytotoxicity, In Vivo Toxicity, and Cellular Uptake, Advanced Healthcare Materials, June 2015, Wiley,
DOI: 10.1002/adhm.201500298.
You can read the full text:
Resources
Contributors
The following have contributed to this page
